VS
Vivek Singla
About Vivek Singla
Vivek Singla has 16 years in corporate governance. Holds Director and Additional Director roles. Currently with 1 company, including Rouzel Pharma Private Limited and Shivvalley Marketing Services Private Limited. Formerly with 3 companies, such as Janaxa Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Rouzel Pharma Private Limited
U24232CH2011PTC032830
|
Director | 23 Mar 2011 | 2011 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Janaxa Pharmaceuticals Private Limited
U24232CH2012PTC033849
|
Director | 07 Jun 2012 | 2012 | Active |
Shivvalley Marketing Services Private Limited
U51909DL2009PTC192715
|
Additional Director | 27 Aug 2009 | 2009 | Strike Off |
|
Manglam Urban Township Private Limited
U70109CH2011PTC032729
|
Director | 08 Feb 2011 | 2011 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vivek Singla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivek Singla
Vivek Singla has 16 years in corporate governance. Holds Director and Additional Director roles. Currently with 1 company, including Rouzel Pharma Private Limited and Shivvalley Marketing Services Private Limited. Formerly with 3 companies, such as Janaxa Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
Vivek Singla is associated with 1 company as Director and Additional Director.
Vivek Singla has expertise in General Business.
Vivek Singla has 16 years in corporate governance.